-
Recent Posts
Archives
Categories
Meta
Tag Archives: Primary Progressive
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Recent studies indicate that higher strength disease modifying therapies (DMTs) may slow disability progression in secondary progressive multiple sclerosis (MS), as well as reduce the number of relapses. There have also been trials in primary progressive MS but these, most … Continue reading →
Advertisement